Skip to content
naulon

Not checkedNot checked for notices yet.

Survival prediction for non-small cell lung cancer patients treated with CT-guided microwave ablation: development of a prognostic nomogram

Sheng Xu, Jing Qi, Bin Li and 1 more

International Journal of Hyperthermia · 2021

doi:10.1080/02656736.2021.1914353 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Objectives To explore the outcomes of CT-guided percutaneous microwave ablation (MWA) in non-small cell lung cancer (NSCLC) patients, and then develop an effective nomogram to predict the survival. Methods NSCLC patients treated with MWA were randomly allocated to either the training cohort or the validation cohort (3:1). The primary outcome measurement was overall survival (OS), whose predictors were identified by univariate and multivariate analyses in the training cohort. Then, a predictive nomogram was developed to predict the OS, with the predictive accuracy evaluated by C-statistic and receiver operating characteristic in both the training and validation cohorts. Results A total of 234 patients (training cohort: n = 176; validation cohort: n = 58) and 271 tumors with a median OS of 17.0 ± 12.2 months were included. The predictors selected into the nomogram included tumor diameter (hazard ratio [HR], 2.12; 95% confidence interval [CI], 1.37-3.30; p < 0.001), extrapulmonary metastases (HR, 1.77; 95% CI, 1.06–2.95; p = 0.030), tumor stage (HR, 1.38; 95% CI, 1.07–1.79; p = 0.013), tumor type (HR, 2.00; 95% CI, 1.48–2.72; p < 0.001) and post-MWA TKIs (HR, 0.55; 95% CI, 0.34–0.89; p < 0.001), based on the results of univariate and multivariate analyses. The C-statistic showed good predictive performance, with a C-statistic of 0.838 (95% CI, 0.779–0.897) internally and 0.808 (95% CI, 0.695–0.920) externally (training cohort and validation cohort, respectively). Conclusions The nomogram was effective in predicting the OS in NSCLC patients treated with MWA, and could be applied to identify patients who may benefit most from MWA and be helpful for clinical decision making.

Abstract licence: CC BY-NC

References43

    40 more references, whose wording the paper’s licence keeps private.

    All 43 references

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.